Evaluation of the Genetic Toxicity of the Peroxisome Proliferator and Carcinogen Methyl Clofenapate,Including Assays Usin Muta TM Mouse and Big Blue™ Transgenic Mice

Abstract

The rodent liver carcinogen and hepatic peroxisome proliferator methylclofenapate (MCP) has been evaluated for genetic toxicity in a range of in vitro and rodent genotoxicity assays. It gave a negative response in each of the following assays: mutagenicity to S.typhimurium and E.coli (± S9 mix, plate and pre-incubation assays), clastogenicity to cultured human lymphocytes and CHO cells (± S9 mix), a mouse bone marrow micronucleus assay (24h and 48h sampling), a rat liver assay for UDS in vivo (12h sampling), assays for lac I (Big Blue™) and lac Z (Muta™ Mouse) mutations in the liver of transgenic mice, and an assay of the ability of MCP to modify the mutagenicity to the liver of dimethylnitrosamine in both transgenic mutation assays. The micronucleus and UDS assays were conducted using a single administration of MCP at its maximum tolerated dose, while the transgenic assays were conducted using nine daily administrations of MCP at its cancer bioassay dose level. These nine daily administrations were shown to double the weight of the liver of non-transgenic, Big Blue™ and Muta™ Mice, as well as leading to a dramatic proliferation of peroxisomes (electron microscopy) in the livers of each strain. These changed parameters had returned to control levels when the mutation analyses were conducted (10 days after the final dose of MCP). Despite the liver enlargement observed following MCP administration, no evidence of mitotic activity was observed in treated livers, although an increased number of cells were undergoing replicative DNA synthesis during the final 3 days of the 9 days of administration (BUdR assessment of S-phase). Liver biochemistry parameters (ALT, AST, AP, CK, GGT and albumin) were unaffected by the chronic (9 day) administration of MCP indicating an absence of hepatic toxicity, These combined observations favour a non-genotoxic mechanism of action for the hepatic carcinogenicity of MCP.

The clastogenicity in vitro of the peroxisome proliferator Wyeth 14,643 has been confirmed in CHO cells, but it is noted that this chemical is more soluble than is MCP. In particular, at the highest dose level at which MCP could be tested, Wy 14,643 was also nonclastogenic.

Get full access to this article

View all access options for this article.

References

Reddy JK , Lalwani ND , Reddy MK & Qureshi SA Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cander Res 1982; 42: 259-66.

Stanley LA , Devereux TR , Foley J. , Lord PG , Maronpot RR , Orton TC and Anderson MW Ras mutations in methylclofenopate-induced B6C3F 1 and C57 BL/10J mouse liver tumours. Carcinogenesis 1994; 15: 1125-1131.

Elliott BM & Elcombe CR Lack of DNA damage or lipid peroxidation measured in the rat liver following treatment with peoxisomal proliferators. Carcinogenesis 1987; 8: 1213-18.

Ashby J. & Lefevre PA Mitogenesis, micronuclei and carcinogenesis in the rat liver: some basic inconsistencies . Environ Mol Mutagen 1992; 20: 29-38.

de Serres FJ & Ashby J (eds). Evaluation of Short-Term Tests for Carcinogenesis: Report of the International Collaborative Programme. Progress in Mutation Research, I, New York: Elsevier, 1981.

Gatehouse DG , Wilcox P. , Forster R. , Rowland IR & Callander RD Bacterial mutation assays. In: Kirkland DJ (ed): Basic mutagenicity tests: UKEMS recommended procedures . Cambridge University Press: Cambridge , UK, 13-61, 1990.

Lefevre PA & Ashby J. The effects of pre-incubation period and norharman on the mutagenic potency of 4-dimethylaminoazobenzene and 3'-methyl-4-dimethylaminoazobenzene in S. typhimurium. Carcinogenesis 1981; 2: 927-31.

Ames BN , McCann J. & Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat Res 1975 ; 31: 347-64.

Elliott BM , Combes RD , Elcombe CR , Gatehouse DG , Gibson GG , Mackay JM & Wolf RC Alternatives to Arochlor 1254 induced S9 in in vitro genotoxicity assays: Report of the UK Environmental Mutagen Society Working Party. Mutagenesis 1992; 7: 175-7.

10.

Scott D. , Dean BJ , Danford ND & Kirkland DJ Metaphse chromosome aberration assays in vitro. In: Kirkland DJ (ed): Basic mutagenicity tests. UKEMS recommended procedures. Cambridge University Press: Cambridge, UK; 62-86, 1990.

11.

Bean CL , Armstrong MJ & Galloway SM Effect of sampling time on chromosome aberration yield for seven chemicals in chinese hamster ovary cells. Mutat Res 1992; 265: 31-44.

12.

Bean CL & Galloway SM Evaluation of the need for a late harvest time in the assay for chromosome aberrations in chinese hamster ovary cells. Mutat Res 1993; 292: 3-16.

13.

Ashby J. The efficient preparation of corn oil suspensions. Mutat Res 1987; 187: 45.

14.

Mackay JM & Elliott BM Dose-ranging and dose-setting for in vivo genetic toxicity studies. Current Issues in Mutagenesis and Carcinogenesis, No. 29, Mutat Res 1992; 271: 97-9.

15.

Sheldon T. , Richardson CR & Elliott BM Inactivity of methylene chloride in the mouse bone marrow micronucleus assay . Mutagenesis 1987; 2: 57-9.

16.

Tinwell H. & Ashby J. Comparison of acridine orange and giemsa stains in several mouse bone-marrow micronucleus assays, including a triple dose study. Mutagenesis 1989; 4: 476-81.

17.

Ashby J. , Lefevre PA , Burlinson B. & Penman MG An assessment of the in vivo rat hepatocyte DNA-repair assay. Mutat Res 1985; 156: 1-8.

18.

Lefevre PA & Ashby J. Investigations into the reported ability of cimetidine to initiate UDS in rat hepatocyte primary cultures. Environ Mutagen 1985; 7: 833-7.

19.

Soames AR , Lavender D. , Foster JR , Williams SM & Wheeldon EB Image analysis of bromodeoxyuridine (BrdU) staining for the measurement of S-phase in rat and mouse liver. J Histochem Cytochem 1994; 42: 939-944.

20.

Tinwell H. , Lefevre PA & Ashby J. Mutation studies with dimethylnitrosamine in young and old lac I transgenic mice. Mutat Res 1994; 307: 501-8.

21.

Tinwell H. , Lefevre PA & Ashby J. Response of the Muta™mouse Lac Z/Gal E- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (Lac I) responses. Mutat Res 1994; 307: 169-73.

22.

Kennelly JC , Waters R. , Ashby J. , Lefevre PA , Burlinson B. , Benford DJ , Dean SW & Mitchell I de G. In vivo rat liver UDS assay. In: Kirkland DJ & Fox M (eds). Supplementary mutagenicity tests. UKEMS recommended procedures; Cambridge University Press: Cambridge, UK, 52-77, 1993.

23.

Auton TR , Kelly M. & Styles JA A mathematical model for the cellular dynamics and labelling kinetics governing the response of rat mouse, hamster and guinea pig hepatocytes to methylclofenapate . In: Proc 7th International Conference on Mathematical and Computer Modelling, Chicago, IL ( 1989).

24.

Goel SK , Lalwani ND & Reddy JK Peroxisome proliferation and lipid peroxidation in rat liver. Cancer Res 1986; 46: 1324-30.

25.

Bentley KS , Covell DL , Leibowitz R. & Gerber KM

Induction of chromosome aberrations in cultured human lymphocytes by the peroxisome proliferator and hepatocarcinogen Wy 14, 634. Environ Mol Mut

1993; 21: Supplement 22, 6.

26.

Ashby J. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens. Mutagenesis 1986; 1: 3-16.

27.

Ashby J. & Leigibel U. Transgenic mouse mutation assays: potential for confusion of genotoxic and non-genotoxic carcinogenesis: a proposed solution. Environ Mol Mut 1992; 20: 145-7.

28.

Ashby J. & Leigibel U. Dosing regimens for transgenic animal mutagenesis assays. Response from the authors. Environ Mol Mut 1993; 21: 120-1.

29.

Mirsalis J. Dosing regimens for transgenic animal mutagenesis assays. Environ Mol Mut 1993; 21: 118-19.

30.

Reddy JK , Azarnoff DL & Hignite CE Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogen. Nature 1980; 283: 397-8.

31.

Bursh W. & Schulte-Hermann R. Synchronization of hepatic DNA synthesis by scheduled feeding and lighting in mice treated with the chemical inducer of liver growth α-hexachlorocyclohexane. Cell Tissue Kinet 1983; 16: 125-34.